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ABSTRACT 
Introduction: Diabetic peripheral neuropathy (DPN) is one of the common complications of diabetes mellitus. Aim: To 
find out gender based differences in frequency of DM, age at diagnosis of DM and subsequent onset of DPN, duration 
of DM and DPN and electrophysiological patterns. Methodology: On the basis of non-probability purposive sampling, a 
cross sectional study was conducted at Neurology department, Mayo Hospital, Lahore. Patients fulfilling the ADA criteria 
for DM, and DPN were included in the study. Data was analyzed using SPSS 16 version. Results: A total of 125 patients 
were included in the study with 57/125 (45.6%) males and 68/125 (54.4%) females. This difference in gender based 
frequency was not statistically significant (p<0.324]. Although mean age of females [51.83+10.04 yrs.] was lower 
than that of males [53.29+9.39 yrs.] but this difference was also not significant (p<0.504). There was no significant 
difference (p<0.685) in the mean age at onset of DM in men (42.03+9.97yrs) and women (41.24+10.62yrs). Both 
genders took a mean period of 08 yrs to develop DPN. The mean age of onset of DPN was 50.87+9.43yrs in men and 
49.25+10.62yrs in women and this was not statistically significant (p<0.374). Sensory-motor mixed polyneuropathy 
was the commonest electrophysiological pattern (51%) seen in both the genders. Conclusion: In our study, gender 
based differences in DPN are statistically not significant with respect to frequency of diabetes, age at diagnosis of diabe-
tes or at onset of DPN, duration of DM before onset of DPN and electrophysiological patterns. More studies are required 
to settle whether gender based differences in onset and progression of diabetic neuropathy exist.
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INTRODUCTION
‘Diabetic Peripheral Neuropathy (DPN)’ is one of the 
most common complications of diabetes (both type-1 & 
type-2 diabetes). DPN is defined as ‘The presence of 
symptoms and/or signs of peripheral nerve dysfunction 
in people with diabetes after exclusion of other causes’. 
DPN may be asymptomatic[1]. Diagnosis of DPN is both 
on clinical basis & electrodiagnostic analysis. The man-
agement includes both non-pharmacologic & pharmaco-
logic approaches. Studies about DPN have reported a 
wide range of prevalence estimates. The reported preva-
lence of diabetic neuropathy varies from less than 5 to 
60 percent [2] with average standing at 26.4% [3]. 
Approximately 40-50% of the patients developing DPN 
further develop painful neuropathy [4]. DPN has a statis-
tically significant negative impact on the quality of life 
[5]. Very little data on onset and progression of diabetic 
peripheral neuropathy with reference to gender is avail-
able in international literature. Studies from Western 
countries suggest that male gender is more prone to 
diabetic neuropathy than females [6;7]. Few data are 
available in Asian populations. From Pakistan,ours is 
probably the first study on gender based differences in 
DPN. We have tried to find out gender based differences 
in prevalence, age at diagnosis of DM and subsequent 
onset of DPN and finally duration of both DM and DPN 
symptoms. Gender based differences in electrophysi-
ological patterns were also sorted out.
MATERIALS AND METHODS
This was a retrospective cross sectional study carried out 
at Department of Neurology, Mayo Hospital, Lahore, 
over a period of six months from September, 2011 to 
February, 2012. Patients fulfilling the inclusion criteria 
were enrolled on the basis of non-probability purposive 
sampling technique. Diabetes mellitus was diagnosed as 
per American Diabetes Association (ADA) guidelines i.e. 
random blood sugar >200mg/dL or fasting blood sugar 
> 126 mg/dL.  Diabetic neuropathy was diagnosed by 
the combination of more than one abnormal result of 
10-gm monofilament, pinprick sensations, vibration 
perception and ankle reflexes [8]. Electrophysiological 
diagnosis of DPN was based on American Academy of 
Neurology (AAN), American Association of Electrodiag-
nostic Medicine (AAEM), and American Academy of 
Physical Medicine and Rehabilitation (AAPM&R) guide-
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line [9]. After taking consent, patients were subjected to 
electrophysiology. Standardized techniques for nerve 
conduction study (NCS) with temperature control and 
fixed distances were applied. Measurements of laten-
cies, amplitudes, conduction velocities and F-waves 
were done in nerves of upper and lower limbs. Inclusion 
criteria consisted of: (1) Diagnosed patients of diabetes 
mellitus (Type 1 or 2) with symptoms of peripheral 
neuropathy (2) Both males & females. (3) ADA clinical 
criteria for DPN. (4) Electrophysiological criteria for DPN 
as mentioned above. Exclusion criteria were based on 
History, examination or investigations showing: (1) 
Hereditary neuropathies. (2) Chronic Inflammatory Demy-
elinating Polyradiculopathy. (3) Renal or Thyroid disease. 
(4) Alcoholics or toxic drug intake; Nutritional deficien-
cies. (5) Malignancy or an autoimmune disorder. Data 
was collected on a Performa which included: (a) History. 
Onset & duration of DM & DPN were equated with the 
date of first symptom identification (b) Physical examina-
tion. (c) Electrodiagnostic test.  Statistical analysis of 
data was done using independent Student’s t-test 
(SPSS-16). Data has been presented as the mean with 
standard deviation (SD). Gender based differences in 
DPN have been studied with respect to:-
1. Gender vs. Frequency of DM.
2. Gender vs. Age of sample. 
3. Gender vs. Age at diagnosisof DM & at onset of DPN. 
4.  Gender vs. Duration of both DM & DPN (symptomatic). 
5. Gender vs. Electrophysiological patterns in DM.
Diagram-1
Gender vs. Age at diagnosis of DM & onset of DPN
RESULTS
One hundred and thirty one patients of symptomatic 
DPN were selected from amongst those visiting the 
hospital OPD. There was drop out of six cases. So, one 
hundred and twenty five patients (n=125) went through 
the study, out of which 57/125 (45.6%) were male and 
68/125 (54.4%) were female. Male/Female ratio was 
1:1.1. Though, frequency of DM was more in female 
gender but this conclusion was‘statistically not signifi-
cant (P < 0.324)’. Mean age of the entire sample 
(n=125) was 52.52+9.05 yrs. with mean age of 
females 51.8+10.04 yrs and of male gender 53.29 + 
9.39 yrs. Though mean age of female diabetics in the 
sample was less than that in males implying early onset 
of DM & DPN   but this gender based difference was 
‘statistically not significant (P < 0.504). Age at diagno-
sis of DM was 42.03+9.97yrs. in males while in female 
gender it was 41.24+10.62yrs (Diagram-1). However, 
in statistical terms, this gender based difference in age 
at diagnosis of DM was found to be ‘not significant (P < 
0.685)’. The age of onset of DPN  was 50.87+9.43 yrs. 
in males and 49.25+10.6yr  in females  but this differ-
ence was also ‘statistically insignificant (P < 0.374) 
(Diagram 1. Mean duration of diabetes before onset of 
DPN in males was 8.83 +6.89 yrs. (p<.000) and 
8.01+6.06 yrs in females (p<.001). On comparing this 
data, both genders took same period before the onset of 
symptomatic DPN (Diagram-1). Difference in mean 
duration of diabetes and mean duration of symptoms of 
DPN after onset was less [8.21 mean yrs. (+ 6.06); p 
<.004] in females than in male gender [9.01 mean yrs. 
(+ 6.99); p <.075]. This difference also  points that 
females are more susceptible to an early onset of DPN 
(Diagram-2). Duration taken for the development of DPN 
was calculated by subtracting the age at diagnosis of DM  
from the age at diagnosis of DPN. Considering the 
electrophysiological patterns with reference to gender, 
five major neuropathic patterns constituted more than 
92% of entire electrophysiological profile (Diagram-2). 
The commonest electrophysiological pattern was 
sensory-motor mainly axonal polyneuropathy and found 
in 51% (63/125) cases with almost an equal number of 
males (33/63 i.e. 52.38%) and females (30/63 
i.e.47.62%). Second commonest pattern of ‘sensory 
axonal polyneuropathy’ was found in 22% (28/125) 
cases, again more frequent in female (17/28 i.e. 
60.72%) than in male diabetics (11/28 i.e. 39.28%). 
Sensory-motor demyelinating polyneuropathy was found 
in 3% (4/125) of cases.  This was more frequent in 
female (3/4 i.e. 66.67%) than in male gender (1/4 i.e. 
33.33%). Normal electrophysiology was seen in 13% 
(16/125) of symptomatic DPN patients with more 
females (9/16 i.e. 56.25%) than males (7/16 i.e. 
43.75%). Carpal Tunnel Syndrome (CTS) had predilec-
tion for female gender. CTS mainly manifested as part of 
polyneuropathy but in 3% females (4/125), it presented 
as mononeuropathy alone. While considering the entire 
electrophysiology, statistics do not yield any significant 
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relationship (P < 0.098) between gender & rest of the 
electrophysiological profile.
Diagram-2
Gender vs. Duration of DM & DPN
DISCUSSION
Only few studies have been published internationally so 
far addressing the gender based differences in DPN 
suggesting that male being more affected by diabetic 
neuropathy than females [6,7]. The primary risk factor for 
the development of diabetic neuropathy is related to 
duration and severity of hyperglycemia [10]. This is first 
study on gender based differences in diabetic peripheral 
neuropathy from Pakistan. We studied the gender based 
differences with respect to frequency of DM, age at 
diagnosis of DM and subsequent onset of DPN with 
respect to duration of DM, and electrophysiological 
patterns. We also compared our results with previously 
published studies.
Gender vs. frequency of DM: Regarding frequency of 
diabetes, factors like age, socioeconomic status & occupa-
tion have higher correlation with the occurrence of diabetes 
among both sexes. According to a study by Kaur & Bishoni 
(2010), reproductive status has significant impact on the 
occurrence of type-2 diabetes among female individuals 
[11]. Indians have the highest prevalence of diabetes among 
Asian countries [12]. In 2001, a study by Gale and Gillespie 
revealed that regarding gender based prevalence of diabe-
tes mellitus, male excess is a consistent finding in popula-
tions of European origin. However, populations mostly of 
non-European origin, characteristically show a female bias 
[13]. In a study conducted by Aaberg & colleagues (2008), 
out of 376 reviewed charts of diabetics, there were more 
females (59%) than males (41%) [7]. Our study supports the 
findings of these studies. Though in our study male-female 
ratio is 1: 1.1 i.e. diabetes is more prevalent in female 
(54%) than in male gender (46%) but this finding is statisti-
cally not significant (P<0.324).
Gender vs. Age: Irrespective of gender, prevalence of 
diabetes increases with increasing age. Age-
standardized prevalence of diabetes and prediabetes in 
both sexes is 9.7% [14]. In a multicenter study on the 
prevalence of diabetic neuropathy, the average ages in 
Italy ranged from 56 yrs.in men & 58yrs. in women 
(sample age:57 mean yrs.) [15]. In an Indian study, 
average ages in diabetics ranged from 57 yrs. in men to 
54 yrs. in women (sample age:55 mean yrs.) [11]. In our 
study, as well, age of males in the sample is 53 mean 
yrs. while it is lesser(earlier) in female gender i.e. 52 
mean yrs. (sample age: 52.5 mean yrs.). Our values are 
even lesser to those in the Indian study. So, one may 
conclude that in Asians mean age of diabetics is lesser 
than that in the Europeans. Interestingly, in both the 
Asian studies, mean age of female gender is less than 
that in males. This implies an early onset of DM & DPN 
in female gender. However, in our sample, the difference 
in the mean ages of both sexes is statistically not signifi-
cant (P < 0.504).
Gender vs. Age at diagnosis of DM: Gender related 
factors are involved in the onset & transmission of diabe-
tes from one generation to the next. Age at onset is an 
indicator of genetic susceptibility. The stronger the 
genetic component, the earlier is the onset of the 
disease and the greater the risk in the first degree 
relatives. Male gender seems to be more susceptible to 
gestational events predisposing to type-1 diabetes [16]. 
Studies reveal that age at diagnosis of diabetes in Indian 
males is 48.07 yrs. (+ 6.80) while in female gender it is 
46.05 yrs. (+ 5.61). In Iranian population mean age at 
diagnosis of DM stands at 44.5 yrs.[10]. As compared to 
international data, in our study the mean age of the 
sample(41.63 mean yrs.) as well as mean ages in both 
the genders [Male: 42.03 yrs. (+ 9.97); Female: 
41.24yrs. (+10.62)] at diagnosis of DM are low with a 
lower (earlier) mean age in females. Considering above 
statistics, amongst Asian countries are we even more 
susceptible than Iranian & Indian population in contract-
ing diabetes at an earlier age? Age of diagnosis of DM in 
female gender is even lesser than that in males which 
means an earlier onset of DM in females.  However, in 
our sample, gender based difference in age at diagnosis 
of DM is not significant (P<0.685).
Gender vs. Age at onset of DPN: In study, standard 
ADA criteria have been used for the diagnosis of DPN. 
Onset of DPN is equated with the date of first identifica-
tion of neuropathy symptom. Deteriorating levels of 
glycemic control are associated with increasing likeli-
hood of DPN. A difference in the progression of diabetic 
neuropathy between men & women may exist. Fedele D 
et al (1997) state that severity of neuropathy increases 
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both with age and duration of diabetes [15]. However, 
Straub & colleagues (1996) state that there is no age 
related impact of duration of diabetes on cardiovascular 
autonomic nervous function [17]. As per international 
data, mean age of onset of DPN is 08 yrs. after the 
diagnosis / onset of DM. In 7.5% cases, age of onset of 
DPN is same as age of diagnosis of DM. According to 
Davies & Katulanda et al, increased frequency of DPN is 
seen in females [3;18]. In our study, in both genders, there 
was a significant difference (P<0.001) in the age at 
diagnosis of DM (42.03 mean yrs. in male & 41.24 
mean yrs. in female gender) and age at onset of DPN 
(50.87 mean yrs. in male & 49.25 mean yrs. in female 
gender). Both genders, after the onset of diabetes, took 
almost an equal mean period of about eight years before 
there was onset of symptoms of DPN. So, the gender 
based difference in age at onset of DPN is not statisti-
cally significant (P<0.374). Gregersen et al have also 
reported no sex-specific difference in the onset of DPN 
[19].
Gender vs. duration of DM & duration of DPN: In 
prognostic terms, about 50% of diabetics suffer from 
neuropathy between 25-30 yrs. after the diagnosis of 
DM [20]. Prevalence of sensorimotor neuropathy is signifi-
cantly high in patients with long duration of DM [16]. In 
a multicenter study, patients with disease duration of 
12.4 yrs. (+ 8.4) had mild neuropathy & those with 
duration of 15.6 yrs. (+ 9.7) had severe neuropathy 
[15]. Nevertheless, Fraser & colleagues state that no 
consistent relationship exists between onset of neuropa-
thy and age, sex & duration of diabetes [21]. In our study, 
difference in mean duration of diabetes & duration of 
symptoms of DPN after onset is less in female gender 
than in males. Is this statistically significant (P<0.004) 
difference points to more susceptibility of female gender 
to DPN?
Gender vs. Electrophysiological patterns: Diabetic 
peripheral neuropathy (DPN) also known as ‘Distal 
Symmetric neuropathy’ is the most commonly recognized 
electrophysiological form of diabetic neuropathy [22]. 
According to an Indian study, irrespective of gender, 
commonest electrophysiological pattern in diabetics is 
that of sensory-motor mixed polyneuropathy [23]. Bloom-
garden also states that the most commontype of diabetic 
neuropathy is distal symmetrical mixed motor and 
sensory neuropathy, comprising almost 70% of cases of 
diabetic neuropathy [24]. In our study, as well, sensory-
motor mixed polyneuropathy (SM Mixed PN) is almost 
equally common in both the genders and constitutes 
more than 51% of entire electrophysiological spectrum. 
CTS has predilection for female gender. As a whole, 
gender had no significant association with electrophysi-
ological patterns (p<0.098).
Diagram-3
Gender vs. Electrophysiological Profile
CONCLUSION
In conclusion , our study showed that gender based 
differences in DPN are statistically not significant with 
respect to frequency of diabetes, age at diagnosis of 
diabetes or at onset of DPN, duration of DM before 
onset of DPN and electrophysiological patterns. Larger 
studies are required to settle whether gender based 
differences in onset and progression of diabetic 
neuropathy exist.
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